Naslov
POST-TRANSPLANT HLA DONOR-SPECIFIC ANTIBODIES MONITORING IN KIDNEY TRANSPLANT RECIPIENTS WITH PRE-TRANSPLANT DONOR-SPECIFIC ANTIBODIES – CASE REPORT

Autori
Burek Kamenarić, Marija ; Martinez, Natalija ; Štingl Janković, Katarina ; Maskalan, Marija ; Grubić, Zorana ; Žunec, Renata

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Abstract Book / - , 2022, 28-28

Skup
5th Congress of Mediterranean Kidney Society (MKS)

Mjesto i datum
Dubrovnik, Hrvatska, 29.09.-02.10.2022

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
HLA ; DSA ; kidney transplantation

Sažetak
GOALS: Pretransplant donor-specific antibodies (pre-tx DSA) are associated with an increased risk of antibody-mediated rejection (AMR) and allograft loss. Following transplantation (tx), the level of DSAs may increase, decrease, remain persistent or be completely cleared from the recipient's blood and thus should be carefully and continuously monitored in the post-transplant period. MATERIAL AND METHODS The patient was a 46-year-old male waitlisted in September 2019 for the second kidney tx. The presence of HLA antibodies detected with the Luminex Single Antigens beads method (LSA1, LSA2) for HLA class I and class II antibodies showed that the patient was highly immunized, with a highest virtual panel of reactive antibodies (vPRA) of 92%. The complement-dependent cytotoxicity (CDC) PRA at the time of tx was 44% pointing to the presence of cytotoxic complement binding HLA class I antibodies. RESULTS In January 2020, the patient received kidney offer from cadaveric donor. The donor/patient ABCDRDQ mismatch was 21011, with Luminex results positive for the presence of pre-tx HLA class I DSAs with low median fluorescence intensity (MFI: 1300- 1700). The CDC crossmatch was negative, excluding the presence of cytotoxic HLA class I DSAs. The plasmapheresis was performed and Luminex test results turned negative for the presence of pre-tx DSAs. The tx was carried out and the patient continued to be carefully immunologically monitored. Seven months after tx, the pre-tx existing DSAs reappeared with the same low MFI values as before tx and persisted equally positive till today. The kidney function is stable, without the episodes of AMR. CONCLUSION The decision about performing tx with pre-tx DSA present should be made carefully and detailed pre- tx and especially post-tx DSA monitoring are important to improve individual risk stratification for kidney allograft loss.

Izvorni jezik
Engleski

POVEZANOST RADA